August 22nd, 20242024-08-22Takeda Releases New Report to Support Health System Readiness for Rare Diseases in Canada June 21st, 20242024-06-21Takeda’s HyQvia® Approved as Replacement Therapy for Primary Humoral Immunodeficiency and Secondary Humoral Immunodeficiency in Pediatric Patients 2 years of Age and Older All News